Kernel’s Brain-Imaging Helmet Approved For Clinical Trial On Patients Using Ketamine

Kernel’s Brain-Imaging Helmet Approved For Clinical Trial On Patients Using Ketamine


Publication Title
Forbes
Publication/Creation Date
October 31 2021
Creators/Contributors
Will Yakowicz (creator)
Kernel (contributor)
Bryan Johnson (contributor)
Cybin Corp. (contributor)
Alex Belser (contributor)
Yale University (contributor)
Persuasive Intent
Information
Description
"Cybin, a Toronto-based psychedelic therapeutics startup, is sponsoring the study. The study will begin before the end of the year with 15 patients at a ketamine-assisted therapy clinic in Marina Del Rey, California. All patients will go through two rounds of the trial. The first one will be a placebo session with saline solution so the Kernel Flow brain-imaging device can get a baseline for the patient’s neurological activity and the second session patients will get an intramuscular injection of a psychedelic dose of ketamine while wearing the Kernel Flow headset."
HCI Platform
Wearables
Relation to Body
On
Related Body Part
Head, Brain
Marketing Keywords
Cybin, Kernel, Kernel Flow
Source
https://www.forbes.com/sites/willyakowicz/2021/10/31/kernels-brain-imaging-helmet-approved-for-clinical-trial-on-patients-using-ketamine/

Date archived
November 25 2021
Last edited
November 25 2021
How to cite this entry
Will Yakowicz. (October 31 2021). "Kernel’s Brain-Imaging Helmet Approved For Clinical Trial On Patients Using Ketamine". Forbes. Forbes Media LLC. Fabric of Digital Life. https://fabricofdigitallife.com/Detail/objects/5577